PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34726488-7 2021 blaKPC-2 plasmid curing in 28 strains restored CAZ-AVI susceptibility, suggesting that blaKPC-2 was the mediator of CAZ-AVI resistance. avibactam, ceftazidime drug combination 47-54 blaKPC Pseudomonas aeruginosa 0-6 34726488-7 2021 blaKPC-2 plasmid curing in 28 strains restored CAZ-AVI susceptibility, suggesting that blaKPC-2 was the mediator of CAZ-AVI resistance. avibactam, ceftazidime drug combination 116-123 blaKPC Pseudomonas aeruginosa 0-6 34726488-15 2021 The observed correlation between the blaKPC copy number and CAZ-AVI resistance suggests that close monitoring of the susceptibility of the strain during treatment is required. avibactam, ceftazidime drug combination 60-67 blaKPC Pseudomonas aeruginosa 37-43 35019766-6 2022 The CRPA strain PA2207 is a carbapenem- and CZA-resistant strain that harbors a mutated blaKPC gene, named blaKPC-90. avibactam, ceftazidime drug combination 44-47 blaKPC Pseudomonas aeruginosa 88-94 35019766-17 2022 Our study further emphasized that CZA resistance caused by blaKPC gene mutation could be selected in CRPA after CZA therapy. avibactam, ceftazidime drug combination 34-37 blaKPC Pseudomonas aeruginosa 59-65 35019766-17 2022 Our study further emphasized that CZA resistance caused by blaKPC gene mutation could be selected in CRPA after CZA therapy. avibactam, ceftazidime drug combination 112-115 blaKPC Pseudomonas aeruginosa 59-65